339 related articles for article (PubMed ID: 25639315)
1. Cushing's disease: predicting long-term remission after surgical treatment.
Pendharkar AV; Sussman ES; Ho AL; Hayden Gephart MG; Katznelson L
Neurosurg Focus; 2015 Feb; 38(2):E13. PubMed ID: 25639315
[TBL] [Abstract][Full Text] [Related]
2. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
[TBL] [Abstract][Full Text] [Related]
4. Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.
Ramm-Pettersen J; Halvorsen H; Evang JA; Rønning P; Hol PK; Bollerslev J; Berg-Johnsen J; Helseth E
BMC Endocr Disord; 2015 Oct; 15():62. PubMed ID: 26499317
[TBL] [Abstract][Full Text] [Related]
5. Biochemical predictors of outcome of pituitary surgery for Cushing's disease.
Alwani RA; de Herder WW; van Aken MO; van den Berge JH; Delwel EJ; Dallenga AH; De Jong FH; Lamberts SW; van der Lely AJ; Feelders RA
Neuroendocrinology; 2010; 91(2):169-78. PubMed ID: 19907141
[TBL] [Abstract][Full Text] [Related]
6. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
[TBL] [Abstract][Full Text] [Related]
7. The role of bilateral adrenalectomy in the treatment of refractory Cushing's disease.
Wong A; Eloy JA; Liu JK
Neurosurg Focus; 2015 Feb; 38(2):E9. PubMed ID: 25639327
[TBL] [Abstract][Full Text] [Related]
8. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.
Hameed N; Yedinak CG; Brzana J; Gultekin SH; Coppa ND; Dogan A; Delashaw JB; Fleseriu M
Pituitary; 2013 Dec; 16(4):452-8. PubMed ID: 23242860
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors of Long-Term Remission After Surgical Treatment of Cushing's Disease.
Ioachimescu AG
Endocrinol Metab Clin North Am; 2018 Jun; 47(2):335-347. PubMed ID: 29754635
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of the hypothalamic-pituitary-adrenal axis in Cushing's disease diagnosis and remission].
Costenaro F; Rodrigues TC; Rollin GA; Czepielewski MA
Arq Bras Endocrinol Metabol; 2012 Apr; 56(3):159-67. PubMed ID: 22666730
[TBL] [Abstract][Full Text] [Related]
11. Surgical outcomes and multidisciplinary management strategy of Cushing's disease: a single-center experience in China.
Zhang K; Shen M; Qiao N; Chen Z; He W; Ma Z; Shou X; Li S; Zhao Y; Pan L; Liu D; He M; Zhang Z; Li Y; Yao Z; Ye H; Wang Y
Neurosurg Focus; 2020 Jun; 48(6):E7. PubMed ID: 32480378
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test.
Dall'Asta C; Barbetta L; Bonavina L; Beck-Peccoz P; Ambrosi B
Pituitary; 2004; 7(3):183-188. PubMed ID: 16328567
[TBL] [Abstract][Full Text] [Related]
13. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
Abellán Galiana P; Fajardo Montañana C; Riesgo Suárez PA; Gómez Vela J; Escrivá CM; Lillo VR
Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
[TBL] [Abstract][Full Text] [Related]
14. The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery.
Lindsay JR; Oldfield EH; Stratakis CA; Nieman LK
J Clin Endocrinol Metab; 2011 Jul; 96(7):2057-64. PubMed ID: 21508126
[TBL] [Abstract][Full Text] [Related]
15. Postoperative follow-up of Cushing's disease using cortisol, desmopressin and coupled dexamethasone-desmopressin tests: a head-to-head comparison.
Le Marc'hadour P; Muller M; Albarel F; Coulon AL; Morange I; Martinie M; Gay E; Graillon T; Dufour H; Conte-Devolx B; Chabre O; Brue T; Castinetti F
Clin Endocrinol (Oxf); 2015 Aug; 83(2):216-22. PubMed ID: 25660243
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery.
Pouratian N; Prevedello DM; Jagannathan J; Lopes MB; Vance ML; Laws ER
J Clin Endocrinol Metab; 2007 Sep; 92(9):3383-8. PubMed ID: 17595252
[TBL] [Abstract][Full Text] [Related]
17. Criteria of cure and remission in Cushing's disease: an update.
Czepielewski MA; Rollin GA; Casagrande A; Ferreira NP
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1362-72. PubMed ID: 18209875
[TBL] [Abstract][Full Text] [Related]
18. Long-term remission of cyclic Cushing's disease that was diagnosed and treated surgically in non-active phase.
Asano S; Ooka H; Okazaki R; Ishikawa T; Ochiai H; Nakashima M; Ide F; Hasegawa I; Miyawaki S; Nakaguchi H; Murakami M; Ogino Y; Takano K; Matsuno A
Endocr J; 2007 Jun; 54(3):407-12. PubMed ID: 17446656
[TBL] [Abstract][Full Text] [Related]
19. Update on the management of recurrent Cushing's disease.
Rutkowski MJ; Flanigan PM; Aghi MK
Neurosurg Focus; 2015 Feb; 38(2):E16. PubMed ID: 25639318
[TBL] [Abstract][Full Text] [Related]
20. Cushing's disease: pathobiology, diagnosis, and management.
Lonser RR; Nieman L; Oldfield EH
J Neurosurg; 2017 Feb; 126(2):404-417. PubMed ID: 27104844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
